Personal Finance

Pfizer Stock Dives. Its New Guidance Is Disappointing the Market.

Pfizer shares were falling early Wednesday after the pharmaceutical company revised its guidance for 2024. Its new earnings and revenue projections were below expectations, although it raised its cost-saving targets. 

Continue reading this article with a Barron’s subscription.

View Options

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button